XClose

UCL News

Home
Menu

Research News

New technology for diagnosing immunity to Ebola

A promising new approach to detect immunity to Ebola virus infection has been developed by researchers from i-sense in a collaboration between UCL and Imperial College London.

Publication date:

Developing a secure, un-hackable net

A method of securely communicating between multiple quantum devices has been developed by a UCL-led team of scientists, bringing forward the reality of a large-scale, un-hackable quantum network.

Publication date:

Data on 400 million astronomical objects released

Scientists on the Dark Energy Survey (DES), which includes UCL researchers, announce their first three years of data including information on about 400 million astronomical objects such as distant galaxies billions of light years away as well as stars in our own galaxy.

Publication date:

New catalyst for making fuels from shale gas

Methane in shale gas can be turned into hydrocarbon fuels using an innovative platinum and copper alloy catalyst, according to new research led by UCL and Tufts University.

Publication date:

Six UCL papers in Altmetric Top 100

UCL research captured the public’s imagination last year with six papers featuring in the Altmetric Top 100 of 2.2 million research outputs tracked in 2017.

Publication date:

£7m to improve battery technology for electric vehicles

UCL, Synthomer and Nexeon have together been awarded £7million in Innovate UK funding to develop significantly better materials for Li-ion batteries. The work is an essential step to achieving electric vehicles (EVs) with a range of 400 miles and above.

Publication date:

Dementia with Lewy bodies: unique genetic profile identified

Dementia with Lewy bodies has a unique genetic profile, distinct from those of Alzheimer’s disease or Parkinson’s disease, according to the first large-scale genetic study of this common type of dementia which was led by UCL.

Publication date:

Government policies fail to reduce school segregation

Rich and poor children continue to go to different schools in many countries despite government efforts to encourage them to learn together and reduce the achievement gap, according to new research from UCL.

Publication date:

Drug lowers deadly Huntington’s disease protein

The first drug targeting the cause of Huntington’s disease was safe and well-tolerated in its first human trial led by UCL scientists. It successfully lowered the level of the harmful huntingtin protein in the nervous system.

Publication date: